Antibiotics have been one of the most important medical discoveries of the 20th century, saving millions of lives. But overuse and misuse have led to a global problem: antimicrobial resistance. The World Health Organization (WHO) has declared this one of the most pressing threats to public health.

Antimicrobial Resistance – A Silent Crisis
According to the CDC, over 2.8 million antibiotic-resistant infections occur annually in the U.S. alone, with more than 35,000 related deaths. The ECDC monitors similar trends across Europe. The UK government-commissioned Review on Antimicrobial Resistance (O’Neill Report, 2016) warned that by 2050, resistant infections could claim 10 million lives each year.

A New Direction: Passive Immunization with IgY
IgY antibodies offer a promising solution. They act directly on specific pathogens without affecting beneficial bacteria and without contributing to resistance. According to a study published on PubMed (source), IgY extracted from egg yolk can be used effectively to prevent and treat enteric infections.

What Makes IgY Different?

• Targets harmful strains specifically
• Does not damage the “good” bacteria
• Safe for children and immunocompromised individuals
• Can be used alongside other treatments

ActiveImmunity – Innovation Rooted in Science
ActiveImmunity’s biotech platform develops tailored IgY formulas for various applications — from oral supplements to dermatological and veterinary solutions. The approach is natural, non-invasive, and strengthens the body’s own defense mechanisms.

Antibiotics can no longer be relied on as one-size-fits-all solutions. In the face of antimicrobial resistance, alternatives like IgY pave the way for smarter, science-based prevention. This is not just innovation — it’s a responsible shift toward sustainable healthcare.

Praesent nec ex eget nulla porttitor cursus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nunc ac imperdiet lectus. Etiam vestibulum nunc orci, ut ultrices tortor placerat at.